Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 25.0B | 31.1B | 29.8B | 27.8B |
| Cost of revenue | 8.6B | 9.6B | 8.2B | 7.9B |
| Gross profit | 16.3B | 21.5B | 21.6B | 19.9B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 1.2B | 1.7B | 1.6B | 1.0B |
| Operating income | 15.1B | 19.8B | 20.0B | 18.9B |
| Non operating interest income | ||||
| Income | 348.0M | 419.0M | 470.2M | 421.9M |
| Expense | 105.5M | 37.5M | 74.9M | 122.2M |
| Other income expense | — | — | — | — |
| Pretax income | 8.4B | 19.1B | 20.2B | 16.0B |
| Tax provision | 11.6B | 16.0B | 14.7B | 14.3B |
| Net income | -3.2B | 3.1B | 5.5B | 1.7B |
| Basic EPS | -0.5 | 0.5 | 0.9 | 0.3 |
| Diluted EPS | -0.5 | 0.5 | 0.9 | 0.3 |
| Basic average shares | 6.2B | 6.2B | 6.2B | 6.2B |
| Diluted average shares | 6.2B | 6.2B | 6.2B | 6.2B |
| EBITDA | 12.8B | 23.3B | 28.9B | 22.0B |
| Net income from continuing op. | 8.4B | 19.1B | 20.2B | 16.0B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 0 | 0 | 0 | 0 |